Celestica, Inc. (NYSE:CLS – Get Free Report) (TSE:CLS) Director Michael Max Wilson sold 4,168 shares of Celestica stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $333.31, for a total transaction of $1,389,236.08. Following the transaction, the director directly owned 24,718 shares of the company’s stock, valued at $8,238,756.58. This represents a 14.43% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Celestica Price Performance
CLS stock traded up $6.71 during trading on Wednesday, hitting $345.84. 1,714,266 shares of the stock traded hands, compared to its average volume of 2,416,743. Celestica, Inc. has a one year low of $110.54 and a one year high of $435.00. The stock has a market cap of $39.76 billion, a price-to-earnings ratio of 41.82, a P/E/G ratio of 0.79 and a beta of 2.09. The company has a 50 day simple moving average of $337.35 and a 200 day simple moving average of $316.63. The company has a current ratio of 1.26, a quick ratio of 0.73 and a debt-to-equity ratio of 0.36.
Celestica (NYSE:CLS – Get Free Report) (TSE:CLS) last announced its quarterly earnings results on Monday, April 27th. The technology company reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.08 by $0.08. Celestica had a net margin of 6.95% and a return on equity of 36.91%. The firm had revenue of $3.96 billion during the quarter, compared to the consensus estimate of $3.97 billion. During the same period last year, the firm posted $1.20 EPS. The firm’s quarterly revenue was up 52.8% on a year-over-year basis. Celestica has set its FY 2026 guidance at 10.150-10.150 EPS and its Q2 2026 guidance at 2.140-2.340 EPS. Equities analysts expect that Celestica, Inc. will post 9.5 EPS for the current fiscal year.
Institutional Investors Weigh In On Celestica
Analyst Ratings Changes
CLS has been the subject of several analyst reports. Aletheia Capital lifted their price target on shares of Celestica from $330.00 to $410.00 and gave the company a “buy” rating in a report on Tuesday, January 20th. Susquehanna lifted their price target on shares of Celestica from $460.00 to $510.00 and gave the company a “positive” rating in a report on Wednesday, April 29th. Stifel Nicolaus set a $445.00 price target on shares of Celestica in a report on Tuesday, April 28th. UBS Group raised their price objective on shares of Celestica from $355.00 to $400.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Finally, TD Securities upgraded shares of Celestica from a “hold” rating to a “buy” rating and set a $430.00 price objective for the company in a research report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $427.42.
View Our Latest Research Report on Celestica
About Celestica
Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.
The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.
See Also
- Five stocks we like better than Celestica
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.
